MedTrace Logo

Effect of Phlebotomy on Heartrate in Polycythemia Patients

NCT05396170 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-11-13

No results posted yet for this study

Summary

Single-centre, observational within-subject design: patients that undergo phlebotomies regularly for polycythemia will be measured continuously by wearables one week before until one week after a phlebotomy, for three phlebotomies.

Conditions

  • Polycythemia

Interventions

PROCEDURE

phlebotomy

500ml of blood phlebotomized per standard of care to reduce symptoms from polycythemia

Sponsors & Collaborators

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Jaap Jan Zwaginga, MD, PhD · LUMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-21
Primary Completion
2024-12-31
Completion
2025-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05396170 on ClinicalTrials.gov